Be the first person to write a business review for AERES Biomedical Ltd.

AES Laboratoire produces and distributes a complete range of microbial testing instruments and equipment. Whether for quality assurance or national security, clients from 21 countries in industries from food production to pharmaceuticals contract with AES to assure the quality and safety of products and to monitor possible hazards in various working environments. AES is developing and patenting technologies that are more accurate and less time-consuming than traditional laboratory testing methods, including machines that sample the air for bio-contaminants and chemical "litmus tests" that can quickly detect and identify pathogens.

Afexa Life Sciences (formerly CV Technologies) bets that mother nature is always right, but it offers a guarantee just in case. The company uses its ChemBioPrint technology to identify and measure the contents and biological activity of natural health products to ensure batches of herbs and natural compounds are safe and consistent. The company originated as a spin-off from the Faculty of Medicine at the University of Alberta in 1992, and now focuses on the development and manufacturing of natural health products for disease prevention and health maintenance for everyday consumers, especially athletes. COLD-fX is Afexa's lead product and works to strengthen the immune system to prevent colds and the flu.

Affymax, Inc. company was founded in 2001 and is based in Palo Alto, California. Affymax, Inc., a biopharmaceutical company, engages in the development of peptide-based drug candidates to enhance the treatment of serious and life-threatening conditions. The company’s lead product candidate, Hematide, is designed to treat anemia associated with chronic renal failure. Hematide is a synthetic peptide-based erythropoiesis stimulating agent designed to stimulate production of red blood cells. It is conducting Phase III clinical trials for the treatment of anemia associated with chronic renal failure, on dialysis, and pre-dialysis. Affymax has a license, manufacturing, and supply agreement with Nektar Therapeutics AL, Corporation to manufacture, develop, and commercialize Hematide.

Agencourt Biosciences uses more modern weapons to win its battles. The company provides genomic services (including DNA and whole genome sequencing) and nucleic acid purification products that help researchers improve the effectiveness of their drug development process. The company has teamed with a handful of international distributors and marketing partners to get its products into users' hands: These partners include Affymetrix and Life Technologies (formerly Invitrogen). Agencourt Biosciences is a subsidiary of Beckman Coulter.

Agennix develops oral, topical, and other forms of cancer treatments. The company's primary candidate, Talactoferrin, is an oral therapy in the late stages of development that is targeted to treat non-small cell lung cancer, a common and slow-growing type of lung cancer. Its other clinical development-stage candidates include therapies to treat tumors and prostate cancer, as well as non-cancerous conditions such as sepsis and diabetic foot ulcers. Agennix, which has offices in Munich, Germany; Princeton, New Jersey; and Houston, Texas, was formed in 2009 from the merger of Germany-based GPC Biotech AG and US-based Agennix Inc.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.